optic neuropathy semaglutide A new study published in the Open Access journal Pharmaceutics shows that semaglutide, also known as Ozempic, has therapeutic potential for protection against vision loss in people with diabetes. Diabetic retinopathy is Small NAION Risk from GLP-1

Semaglutide restless leg syndrome: Explore the current evidence on whether Ozempic or Wegovy causes RLS, potential indirect mechanisms, nutritional factors, and expert guidance on managing leg symptoms during GLP-1 therapy.

Whilst all GLP-1RAs use has increased, the largest change was seen in patients using tirzepatide and semaglutide ([figure 1B][1])

PlexusDx offers personalized semaglutide therapy starting at $149/month to help optimize your health outcomes

Evidence-based UK guidance for patients with type 2 diabetes.

Learn what standard blood tests detect, how Ozempic and Wegovy affect lab values, and when to disclose semaglutide use to your doctor.

Learn how this combo targets insulin resistance, appetite, and fat loss.